Volume 4, Issue 5, Pages (June 2018)

Slides:



Advertisements
Similar presentations
Jeff Donovan, MD, PhD, FRCPC  JAAD Case Reports 
Advertisements

A case of delayed anaphylaxis after laser tattoo removal
Muneeb Ilyas, BSc, Amit Sharma, MD  JAAD Case Reports 
Successful treatment of lipoatrophy with normal saline
Marc Mrad, MD, MSc, Nakhle Ayoub, MD, Ribal Mehi, MD  JAAD Case Reports 
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany.
Volume 4, Issue 3, Pages (April 2018)
Alopecia after injection of ATX-101 for reduction of submental fat
A generalized fixed drug eruption associated with mycophenolate
JAK inhibitors in dermatology: The promise of a new drug class
Rapid healing of chronic ulcerations and improvement in range of motion after fractional carbon dioxide (CO2) treatment after CO2 excision of hidradenitis.
Volume 3, Issue 3, Pages (May 2017)
An enlarging, ulcerated scalp nodule
Hair repigmentation associated with the use of brentuximab
Development of bullous pemphigoid during nivolumab therapy
Nail discoloration after use of hydroquinone
Volume 2, Issue 2, Pages (March 2016)
Volume 3, Issue 6, Pages (November 2017)
Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor  Gabriela M. Morris, BS, Zachary P. Nahmias,
Flesh-colored papules and nodules on the face
Treatment of psoriasis vulgaris using low-dose naltrexone
A man with macroglossia and hemorrhagic bulla
Deep morphea induced by interferon-β1b injection
Is the hip prosthesis responsible for this rash?
Volume 4, Issue 5, Pages (June 2018)
Volume 4, Issue 10, Pages (November 2018)
Mark D. Heibel, MD, Haley D. Heibel, MS  JAAD Case Reports 
Two cases of maggot debridement therapy in pyoderma gangrenosum
Successful treatment of livedoid vasculopathy with rivaroxaban
Dema T. Alniemi, MD, Laura McGevna, MD  JAAD Case Reports 
Crusted scabies in a patient with methamphetamine abuse
Anjali Shroff, MD, Emma Guttman-Yassky, MD, PhD  JAAD Case Reports 
Volume 1, Issue 1, Pages 7-8 (January 2015)
Recurrent breast cellulitis from a nipple fissure
Diffuse pruritic papules
Nader Aboul-Fettouh, BS, Rajiv I. Nijhawan, MD  JAAD Case Reports 
Volume 4, Issue 6, Pages (July 2018)
Pediatric psoriasis treated with apremilast
An atypical presentation of a rare disease
Jennifer E. Yeh, PhD, William G. Tsiaras, MD, PhD  JAAD Case Reports 
Spiny keratoderma exposes underlying renal cell carcinoma
Eruptive neurofibromas in pregnancy
A case of delayed anaphylaxis after laser tattoo removal
Slowly progressive chest rash in an elderly woman
Stefan Tukaj, PhD, Detlef Zillikens, MD, Michael Kasperkiewicz, MD 
Divalproex sodium: A potential therapy for scleroderma digital ulcers
Papules developing in an old tattoo
Volume 4, Issue 7, Pages (August 2018)
Volume 1, Issue 6, Pages (November 2015)
Olga Vornicova, MD, Gil Bar-Sela, MD  JAAD Case Reports 
Recalcitrant prurigo nodularis treated successfully with dupilumab
Heidrun Mitzel, MD, Stephan Grabbe, MD, Carmen Loquai, MD 
Bilateral sole hyperkeratosis and nonhealing foot mass
Painful violaceus bullae of the hands
Widespread hyperpigmented rash present for 1 year
Extensive skin necrosis
Spontaneous resolution of advanced basal cell carcinoma after short-pulse treatment with hedgehog pathway inhibitor  Audrey A. Jacobsen, BA, John Strasswimmer,
Multisystemic Langerhans cell histiocytosis in an adult
Tofacitinib therapy for children with severe alopecia areata
Lip ulceration in an immunocompromised patient
Well-circumscribed retiform ulcerations
Figurate erythema for 20 years
Volume 3, Issue 6, Pages (November 2017)
Bryan Baillis, MD, John C. Maize, MD  JAAD Case Reports 
Morphea in a patient undergoing treatment with ustekinumab
Brittany G. Craiglow, MD, Brett A. King, MD, PhD 
Alopecia after injection of ATX-101 for reduction of submental fat
Sa Rang Kim, BSc, Nour Kibbi, MD, Brittany G. Craiglow, MD 
Skin-directed radiation therapy for palmoplantar pustulosis
Volume 5, Issue 10, Pages (October 2019)
Presentation transcript:

Volume 4, Issue 5, Pages 443-445 (June 2018) Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib  Sa Rang Kim, BSc, Alexandra Charos, MD, PhD, William Damsky, MD, PhD, Peter Heald, MD, Michael Girardi, MD, Brett A. King, MD, PhD  JAAD Case Reports  Volume 4, Issue 5, Pages 443-445 (June 2018) DOI: 10.1016/j.jdcr.2017.12.003 Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 A, Before treatment with tofacitinib, patient with GDM was unable to appose her hands (positive prayer sign). B, After 8 months of treatment with tofacitinib, she could fully extend her digits. JAAD Case Reports 2018 4, 443-445DOI: (10.1016/j.jdcr.2017.12.003) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 A, Before treatment with tofacitinib, pseudocellulite appearance and linear depressions (groove sign) of the right arm were prominent in patient with EF. B, After 19 months of treatment with tofacitinib and methotrexate, pseudocellulite appearance and linear depressions are resolved. JAAD Case Reports 2018 4, 443-445DOI: (10.1016/j.jdcr.2017.12.003) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions